<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-11T03:46:43Z</responseDate>
  <request identifier="oai:jue.repo.nii.ac.jp:00001693" verb="GetRecord" metadataPrefix="jpcoar_2.0">https://jue.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:jue.repo.nii.ac.jp:00001693</identifier>
        <datestamp>2023-06-19T08:14:30Z</datestamp>
        <setSpec>416</setSpec>
      </header>
      <metadata>
        <jpcoar:jpcoar xmlns:datacite="https://schema.datacite.org/meta/kernel-4/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcndl="http://ndl.go.jp/dcndl/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:jpcoar="https://github.com/JPCOAR/schema/blob/master/2.0/" xmlns:oaire="http://namespace.openaire.eu/schema/oaire/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rioxxterms="http://www.rioxx.net/schema/v2.0/rioxxterms/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns="https://github.com/JPCOAR/schema/blob/master/2.0/" xsi:schemaLocation="https://github.com/JPCOAR/schema/blob/master/2.0/jpcoar_scm.xsd">
          <dc:title>変革期における製薬企業の競争優位の構築に関する研究　－ジェネリック医薬品業界での事例研究を中心としてー（内容の要旨及び審査結果の要旨）</dc:title>
          <dc:title xml:lang="en">A study on establishing a competitive advantage of pharmaceutical companies in the period of change. ーFocusing on case studies of the generics industryー</dc:title>
          <jpcoar:creator>
            <jpcoar:creatorName>広崎, 心</jpcoar:creatorName>
            <jpcoar:creatorName xml:lang="ja-Kana">ヒロサキ, シン</jpcoar:creatorName>
          </jpcoar:creator>
          <jpcoar:subject subjectScheme="Other">製薬企業｜ジェネリック医薬品業界</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">pharmaceutical companies　｜　generics industry</jpcoar:subject>
          <dc:language>jpn</dc:language>
          <dc:type rdf:resource="http://purl.org/coar/resource_type/c_46ec">thesis</dc:type>
          <oaire:version rdf:resource="http://purl.org/coar/version/c_ab4af688f83e57aa">AM</oaire:version>
          <jpcoar:identifier identifierType="URI">https://jue.repo.nii.ac.jp/records/1693</jpcoar:identifier>
          <dcndl:dissertationNumber>博甲第2号</dcndl:dissertationNumber>
          <dcndl:degreeName>博士（経営学）</dcndl:degreeName>
          <dcndl:dateGranted>2018</dcndl:dateGranted>
          <dcndl:dateGranted>2019年3月14日</dcndl:dateGranted>
          <jpcoar:degreeGrantor>
            <jpcoar:degreeGrantorName>日本経済大学大学院</jpcoar:degreeGrantorName>
          </jpcoar:degreeGrantor>
          <jpcoar:file>
            <jpcoar:URI label="変革期における製薬企業の競争優位の構築に関する研究">https://jue.repo.nii.ac.jp/record/1693/files/博士学位論文内容の要旨及び審査結果の要旨_広崎氏_20190608.pdf</jpcoar:URI>
            <jpcoar:mimeType>application/pdf</jpcoar:mimeType>
            <jpcoar:extent>2.6 MB</jpcoar:extent>
            <datacite:date dateType="Available">2019-06-08</datacite:date>
          </jpcoar:file>
        </jpcoar:jpcoar>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
